46 studies found for:    stroke AND san diego | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
22 Recruiting Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.
Condition: Smoking Cessation
Interventions: Drug: placebo;   Drug: varenicline tartrate;   Drug: bupropion hydrochloride;   Drug: Nicotine Replacement Therapy Patch
23 Recruiting A Study to Assess Cardiovascular Outcomes Following Treatment With MK-3102 in Participants With Type 2 Diabetes Mellitus (MK-3102-018)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo
24 Recruiting Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II
Conditions: Aortic Valve Stenosis;   Stroke
Interventions: Device: targeted brain cooling (33°C) by RhinoChill device;   Device: Placebo - current clinical practice, no cooling
25 Unknown  Wireless Monitoring in Obstructive Sleep Apnea Management in Military Veterans: 2 Site Pilot Study
Condition: Obstructive Sleep Apnea
Interventions: Device: Secure digital (SD) card monitoring;   Device: Wireless monitoring
26 Recruiting CARMELINA: Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus at High Vascular Risk
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Linagliptin
27 Recruiting A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: insulin degludec;   Drug: insulin glargine
28 Recruiting Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
29 Recruiting Modulation of Immune Activation by Aspirin
Condition: HIV-1 Infection
Interventions: Drug: Aspirin;   Drug: Aspirin placebo
30 Recruiting Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
31 Recruiting Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Condition: Sialorrhea
Intervention: Drug: MYOBLOC
32 Not yet recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
33 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
34 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
35 Recruiting A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650;   Other: ITCA placebo
36 Recruiting A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CP-690,550
37 Recruiting Changes in Cardiac Output During Delayed Umbilical Cord Clamping
Condition: Cardiac Output, Low
Intervention:
38 Recruiting Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Condition: Heart Failure With Preserved Ejection Fraction
Interventions: Drug: LCZ696;   Drug: Valsartan
39 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
40 Recruiting INcrease Of VAgal TonE in CHF
Conditions: Left Ventricular Dysfunction;   Heart Failure
Interventions: Device: CardioFit® System;   Other: Standard of Care

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results
Indicates status has not been verified in more than two years